0001493152-21-005282.txt : 20210303 0001493152-21-005282.hdr.sgml : 20210303 20210303162539 ACCESSION NUMBER: 0001493152-21-005282 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210210 FILED AS OF DATE: 20210303 DATE AS OF CHANGE: 20210303 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Lisi Steven A. CENTRAL INDEX KEY: 0001702628 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-38892 FILM NUMBER: 21709310 MAIL ADDRESS: STREET 1: 2 ILAN RAMON, SCIENCE PARK CITY: NESS ZIONA STATE: L3 ZIP: 7403635 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Beyond Air, Inc. CENTRAL INDEX KEY: 0001641631 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 473812456 STATE OF INCORPORATION: DE FISCAL YEAR END: 0331 BUSINESS ADDRESS: STREET 1: 825 EAST GATE BOULEVARD, SUITE 320 CITY: GARDEN CITY STATE: NY ZIP: 11530 BUSINESS PHONE: 516-665-8200 MAIL ADDRESS: STREET 1: 825 EAST GATE BOULEVARD, SUITE 320 CITY: GARDEN CITY STATE: NY ZIP: 11530 FORMER COMPANY: FORMER CONFORMED NAME: AIT Therapeutics, Inc. DATE OF NAME CHANGE: 20170117 FORMER COMPANY: FORMER CONFORMED NAME: KokiCare, Inc. DATE OF NAME CHANGE: 20150507 4/A 1 ownership.xml X0306 4/A 2021-02-10 2021-02-12 0 0001641631 Beyond Air, Inc. XAIR 0001702628 Lisi Steven A. C/O BEYOND AIR, INC. 825 EAST GATE BOULEVARD, SUITE 320 GARDEN CITY NY 11530 1 1 0 0 CEO and Chairman of the Board Common Stock 2021-02-10 4 M 0 117112 4.25 A 1051875 D Common Stock 2021-02-10 4 F 0 70388 7.0713 D 981487 D Tranche B Warrant (right to buy) 4.25 2021-02-10 4 M 0 117112 0 D 2018-02-16 2021-02-16 Common Stock 117112 0 D On February 10, 2021, the reporting person exercised a warrant to purchase 117,112 shares of common stock, par value $0.0001 per share, of Beyond Air, Inc. (the "Company") for $4.25 a share. The reporting person paid the exercise price on a cashless basis, resulting in the Company's withholding of 70,388 of the warrant shares to pay the exercise price and issuing to the reporting person the remaining 46,724 shares of common stock of the Company. This Form 4/A amends the Form 4 filed on February 12, 2021 (the "Original Form 4") solely to change the transaction codes in (i) row 1 of Tables I and II from "X" to "M" and (ii) row 2 of Table I from "S" to "F", in each case, to more clearly convey that the reported transactions were exempt from Section 16(b) in accordance with Rule 16b-3. /s/ Steven A. Lisi 2021-03-03